PHARMATECH

Have any questions? Just call us at 720-917-8400

Next Generation CRO/SMO

Solutions Designed For The Studies Of Tomorrow

  • AccessPPM

    AccessPPM

    Solution For Biomarker Focused Trials

  • SMO

    SMO

    Accelerated Patient Recruitment

  • CRO

    CRO

    Next Generation, Full-Service CRO

Get more information about Pharmatech’s experience and services

Services

 

PharmatechBenefits

 

 

 

RecentPress Releases

Paradigm Initiates Genomic Profiling for Pharmatech’s AccessPPM Cancer Registry Program

August 5, 2014

ANN ARBOR, Mich. and DENVER, Aug. 5, 2014 - Paradigm has announced today they have initiated genomic testing for Pharmatech’s AccessPPM Cancer Registry. Pharmatech’s AccessPPM is a cancer registry designed to collect EMR data and genomic information to help best match cancer patients with targeted clinical trials. The AccessPPM program and associated protocol currently includes

Why ChoosePharmatech?

Our core competency is working with small to mid-sized pharmaceutical and biotech companies. Understanding the unique needs of our clients and establishing an ongoing dialogue allows us to offer greater flexibility than many other CROs, both from operational and pricing perspectives.
We understand that project team turnover adversely affects the project as a whole.  To ensure our sponsors consistent Project Management we commit to, and will specify in our contract, not transferring any key project team members to other “more important” client projects.
With over 100 completed projects in oncology we’ve “been there and done that.” Our experience leads to better results, a greater understanding, and thoughtful foresight into all the projects on which we work. We are also a leading innovator in biomarker related research.
Superior customer service is our trademark. We strive to make sure all your needs are met and each project has a specially selected executive oversight team that ensures the entire process runs smoothly.